- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Glyceryl Trinitrate, Isosorbide Dinitrate Removed from Schedule P1: MoHFW
New Delhi: The Ministry of Health and Family Welfare has amended the Drugs Rules, 1945 by removing Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 which contains regulations regarding the retail package size of various drugs.
The amended rules furthermore stated that, for drugs not covered by Schedule P-1, the pack sizes of tablets and capsules should be as follows: if the number of tablets (coated or uncoated) or capsules (hard or soft gelatine) is less than 10, the packing should be made according to the integral number; if the number is more than 10, the pack sizes of tablets and capsules should contain multiples of five or seven.
The Drugs and Cosmetics Rules, of 1945 are the rules which the government of India established through the Drugs and Cosmetics Act, 1940. These rules classify drugs under given schedules and present guidelines for the storage, sale, display, and prescription of each schedule.
Schedule P contains regulations regarding the life period and storage of various drugs and Schedule P-I contains regulations regarding the retail package size of various drugs.
A draft of certain rules further to amend the Drugs Rules, 1945, was published, as required by section 12 read with section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), vide notification of the Ministry of Health and Family Welfare, Department of Health and Family Welfare, number G.S.R. 687 (E), dated the 25th September 2023, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), inviting objections and suggestions from the persons likely to be affected thereby before the expiry of a period of forty-five days from the date on which the copies of the Official Gazette containing the said notification were made available to the public.
Copies of the said Gazette notification were made available to the public on 26th September 2023. In line with this, objections and suggestions received from the public on the said rules have been considered by the Central Government.
Therefore, in the exercise of the powers conferred by section 12 read with section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government, after consultation with the Drugs Technical Advisory Board, has made the following rules further to amend the Drugs Rules, 1945, namely;-
"1. Short title and commencement(1) These rules may be called the Drugs (Second Amendment) Rules, 2024.(2) They shall come into force on the date of their final publication in the Official Gazette.2. In the Drugs Rules, 1945, (hereinafter referred to as the principal rules), in rule 105, in sub-rule (2), in clause (i), after the words, and figure, “multiples of 5”, the word and figure “or 7” shall be inserted.3. In the principal rules, in Schedule P1, under the heading “PACK SIZES OF DRUGS”, the drugs “Glyceryl Trinitrate” and “Isosorbide Dinitrate” mentioned in column 1 and entries relating thereto in columns 2 and 3 shall be omitted."
Also Read:Cipla Gets CDSCO Panel Nod To import, market Human Insulin inhalation powder with inhaler
Doctor of Pharmacy
Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751